메뉴 건너뛰기




Volumn 31, Issue 11, 2012, Pages 1342-1343

A case of recipient bed melt and wound dehiscence after penetrating keratoplasty and subconjunctival injection of bevacizumab

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; CARBOXYMETHYLCELLULOSE; CYANOACRYLATE; MOXIFLOXACIN; PREDNISOLONE ACETATE;

EID: 84867395958     PISSN: 02773740     EISSN: 15364798     Source Type: Journal    
DOI: 10.1097/ICO.0b013e318245c044     Document Type: Article
Times cited : (9)

References (16)
  • 1
    • 2542561964 scopus 로고    scopus 로고
    • Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer
    • Hurwitz H, Fehrenbacher L, Novotny W, et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med. 2004;350:2335-2342.
    • (2004) N Engl J Med , vol.350 , pp. 2335-2342
    • Hurwitz, H.1    Fehrenbacher, L.2    Novotny, W.3
  • 2
    • 38449100932 scopus 로고    scopus 로고
    • Anti-vascular endothelial growth factor therapy for ocular neovascular disease
    • Andreoli CM, Miller JW. Anti-vascular endothelial growth factor therapy for ocular neovascular disease. Curr Opin Ophthalmol. 2007;18:502-508.
    • (2007) Curr Opin Ophthalmol , vol.18 , pp. 502-508
    • Andreoli, C.M.1    Miller, J.W.2
  • 3
    • 0023693837 scopus 로고
    • An animal model for corneal graft rejection in highrisk keratoplasty
    • Hill JC, Maske R. An animal model for corneal graft rejection in highrisk keratoplasty. Transplantation. 1988;46:26-30.
    • (1988) Transplantation , vol.46 , pp. 26-30
    • Hill, J.C.1    Maske, R.2
  • 4
    • 34548279498 scopus 로고    scopus 로고
    • Safety profile of bevacizumab on cultured human corneal cells
    • Yoeruek E, Spitzer MS, Tatar O, et al. Safety profile of bevacizumab on cultured human corneal cells. Cornea. 2007;26:977-982.
    • (2007) Cornea , vol.26 , pp. 977-982
    • Yoeruek, E.1    Spitzer, M.S.2    Tatar, O.3
  • 5
    • 79955957252 scopus 로고    scopus 로고
    • Antifibrotic activity of bevacizumab on human Tenon's fibroblasts in vitro
    • O'Neill EC, Qin Q, Van Bergen NJ, et al. Antifibrotic activity of bevacizumab on human Tenon's fibroblasts in vitro. Invest Ophthalmol Vis Sci. 2010;51:6524-6532.
    • (2010) Invest Ophthalmol Vis Sci , Issue.51 , pp. 6524-6532
    • O'Neill, E.C.1    Qin, Q.2    Van Bergen, N.J.3
  • 6
    • 0033856243 scopus 로고    scopus 로고
    • Expression of vascular endothelial growth factor and its receptors in inflamed and vascularized human corneas
    • Philipp W, Speicher L, Humpel C. Expression of vascular endothelial growth factor and its receptors in inflamed and vascularized human corneas. Invest Ophthalmol Vis Sci. 2000;41:2514-2522.
    • (2000) Invest Ophthalmol Vis Sci , vol.41 , pp. 2514-2522
    • Philipp, W.1    Speicher, L.2    Humpel, C.3
  • 7
    • 44449119809 scopus 로고    scopus 로고
    • The effect of topical bevacizumab on corneal neovascularization
    • Kim SW, Ha BJ, Kim EK, et al. The effect of topical bevacizumab on corneal neovascularization. Ophthalmology. 2008;115:e33-e38.
    • (2008) Ophthalmology , vol.115
    • Kim, S.W.1    Ha, B.J.2    Kim, E.K.3
  • 8
    • 77952550711 scopus 로고    scopus 로고
    • Corneal melt while using topical bevacizumab eye drops
    • Galor A, Yoo SH. Corneal melt while using topical bevacizumab eye drops. Ophthalmic Surg Lasers Imaging. 2010;41:1-3.
    • (2010) Ophthalmic Surg Lasers Imaging , Issue.41 , pp. 1-3
    • Galor, A.1    Yoo, S.H.2
  • 9
    • 0028827625 scopus 로고
    • Synergistic effect of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in vivo
    • Asahara T, Bauters C, Zheng LP, et al. Synergistic effect of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in vivo. Circulation. 1995;92(9 suppl):II365-II371.
    • (1995) Circulation , vol.92 , Issue.9 SUPPL.
    • Asahara, T.1    Bauters, C.2    Zheng, L.P.3
  • 10
    • 10644279947 scopus 로고    scopus 로고
    • Vascular endothelial growth factor and angiogenesis
    • Hoeben A, Landuyt B, Highley MS, et al. Vascular endothelial growth factor and angiogenesis. Pharmacol Rev. 2004;56:549-580.
    • (2004) Pharmacol Rev , vol.56 , pp. 549-580
    • Hoeben, A.1    Landuyt, B.2    Highley, M.S.3
  • 11
    • 47749154829 scopus 로고    scopus 로고
    • Regulating the angiogenic balance in tissues
    • Polling EA, Legesse-Miller A, Haley EM, et al. Regulating the angiogenic balance in tissues. Cell Cycle. 2008;7:2056-2070.
    • (2008) Cell Cycle , vol.7 , pp. 2056-2070
    • Polling, E.A.1    Legesse-Miller, A.2    Haley, E.M.3
  • 12
    • 44349149183 scopus 로고    scopus 로고
    • Regulation of scar formation by vascular endothelial growth factor
    • Wilgus TA, Ferreira AM, Oberyszyn TM, et al. Regulation of scar formation by vascular endothelial growth factor. Lab Invest. 2008;88:579-590.
    • (2008) Lab Invest , vol.88 , pp. 579-590
    • Wilgus, T.A.1    Ferreira, A.M.2    Oberyszyn, T.M.3
  • 13
    • 53149126121 scopus 로고    scopus 로고
    • Vascular endothelial growth factor mediates corneal nerve repair
    • Yu CQ, Zhang M, Matis KI, et al. Vascular endothelial growth factor mediates corneal nerve repair. Invest Ophthalmol Vis Sci. 2008;49:3870-3878.
    • (2008) Invest Ophthalmol Vis Sci , vol.49 , pp. 3870-3878
    • Yu, C.Q.1    Zhang, M.2    Matis, K.I.3
  • 14
    • 65249103986 scopus 로고    scopus 로고
    • Topical Bevacizumab in the treatment of corneal neovascularization: Results of a prospective, open-label, noncomparative study
    • Dastjerdi MH, Al-Arfaj KM, Nallasamy N, et al. Topical Bevacizumab in the treatment of corneal neovascularization: Results of a prospective, open-label, noncomparative study. Arch Ophthalmol. 2009;127: 381-389.
    • (2009) Arch Ophthalmol , vol.127 , pp. 381-389
    • Dastjerdi, M.H.1    Al-Arfaj, K.M.2    Nallasamy, N.3
  • 15
    • 34250365240 scopus 로고    scopus 로고
    • Mechanisms of adverse effects of anti-VEGF therapy for cancer
    • Kamba T, McDonald DM. Mechanisms of adverse effects of anti-VEGF therapy for cancer. Br J Cancer. 2007;96:1788-1795.
    • (2007) Br J Cancer , vol.96 , pp. 1788-1795
    • Kamba, T.1    McDonald, D.M.2
  • 16
    • 66949140795 scopus 로고    scopus 로고
    • Understanding and managing the possible adverse effects associated with bevacizumab
    • Shord SS, Bressler LR, Tierney LA, et al. Understanding and managing the possible adverse effects associated with bevacizumab. Am J Health Syst Pharm. 2009;66:999-1013.
    • (2009) Am J Health Syst Pharm , vol.66 , pp. 999-1013
    • Shord, S.S.1    Bressler, L.R.2    Tierney, L.A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.